Rajshree Upadhyaya | Jaipur | Business Remedies | Dr. Parag Gad has carved a niche for himself by founding xTEP and redefining movement recovery through advanced neuromodulation technology. The journey is rooted in years of deep scientific research and a mission to rethink recovery for patients with neurological disorders. The innovation behind xTEP has been developed through nearly 17 years of work in the fields of neuroplasticity and spinal cord stimulation. Although the technology evolved through years of global research, the company began taking a commercial shape when Dr. Gad returned to India around 2023. In January 2025, he formally established his venture, Vivatronics, laying the operational foundation for xTEP in the country.
xTEP focuses on restoring mobility in individuals who have lost their ability to walk due to conditions such as spinal cord injuries, cerebral palsy, stroke, and multiple sclerosis. The company’s core innovation is a non-invasive neuromodulation device that works by stimulating the spinal cord and activating dormant neural pathways. Unlike traditional rehabilitation methods, this technology uses targeted electrical signals to help the body relearn movement, offering a new path to recovery without the need for surgery. This breakthrough positions xTEP at the intersection of healthcare and deep technology, where scientific precision meets real-world impact.
Approval from the Central Drugs Standard Control Organization
The journey from lab research to practical application involved years of validation, clinical exploration, and regulatory navigation. The device received approval from India’s Central Drugs Standard Control Organization (CDSCO) and was also recognized under the U.S. FDA’s Breakthrough Devices Program, strengthening its credibility as a globally relevant medical solution. By early 2025, manufacturing efforts had begun in Bengaluru, marking a significant step towards improving accessibility and bringing innovation closer to patients who need it the most.
xTEP gained nationwide attention after appearing on Shark Tank India Season 5, where Dr. Parag Gad presented not just a business but a life-changing innovation. He sought Rs. 1 crore for 1% equity, reflecting strong confidence in the technology’s long-term potential. The pitch stood out for its emotional depth and scientific credibility, especially during a live demonstration that showcased how the device could initiate movement in patients, impressing the investors.
Expanding Reach to Rehabilitation Centers
After detailed discussions, the deal was finalized at Rs. 1 crore for approximately 6% equity, along with strategic support in addition to capital. This investment validated both the technology and its potential to transform neurological rehabilitation in India and beyond. More importantly, it helped position xTEP as a serious health-tech startup in a space traditionally dominated by conventional treatment methods.
Since its appearance on the show, xTEP has continued to grow actively and is currently in its expansion phase. The company is extending its reach to rehabilitation centers and exploring opportunities in the home healthcare segment. With a large population in India facing mobility challenges, the demand for effective and scalable solutions is high-creating a strong foundation for the adoption of its neuromodulation therapy solutions.
Today, xTEP represents a unique blend of deep science, purpose-driven innovation, and entrepreneurial vision. What began as years of academic research has evolved into a company working to restore freedom and mobility for countless individuals. Its journey demonstrates how advanced technology, when combined with dedication and a clear sense of purpose, can move beyond the lab to create meaningful, step-by-step impact in people’s lives.
